However, females prevail (14:5) also among the 19 ascertained PDGFRA-mutants, compensating the corresponding 10:4 female-to-male tumor distribution (coherently, Fisher exact test, one-tailed, proved not significant: p = 0.60). The gene discussed is PDGFRA; the disease is neoplasm.